￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The efficacy of afatinib (Gitari) in the second-line treatment of lung squamous cell carcinoma is significantly better than that of first-generation TKI_ Kanghule

2025-10-19 11:44:20

Check Details
Can I stop taking Pozitinib if there are serious side effects while taking it?

2025-10-19 11:44:20

Check Details
Compared with chemotherapy, afatinib can significantly improve the overall survival of patients with common EGFR mutations

2025-10-19 11:44:20

Check Details
Data on the efficacy of afatinib in the treatment of EGFR mutated lung cancer

2025-10-19 11:44:20

Check Details
How much will the out-of-pocket cost of afatinib (Gitari) be after medical insurance in 2021?

2025-10-19 11:44:20

Check Details
How long can patients with lung cancer take afatinib?

2025-10-19 11:44:20

Check Details
Can afatinib be used to treat small cell lung cancer?

2025-10-19 11:44:20

Check Details
Is larotrectinib effective for gene fusion NTRK3?

2025-10-19 11:44:20

Check Details
The advantages of afatinib in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Can patients with lung cancer and brain metastases be treated with larotrectinib?

2025-10-19 11:44:20

Check Details
The price of broad-spectrum anticancer drug larotrectinib after it enters medical insurance

2025-10-19 11:44:20

Check Details
Application of broad-spectrum anticancer drug larotrectinib in lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识